Kangmei Pharmaceutical Co. Ltd. A | Ownership
Companies that own Kangmei Pharmaceutical Co. Ltd. A
China Investment Corp. (Investment Management)
78,380,000
1.78%
0
0.69%
06/30/2017
China Asset Management Co., Ltd.
69,660,801
1.58%
-20,748,047
1.09%
12/31/2017
Guotai Asset Management Co., Ltd.
9,627,697
0.22%
-6,889,560
0.45%
12/31/2017
HuaAn Fund Management Co., Ltd.
7,961,667
0.18%
-4,061,500
0.33%
12/31/2017
Penghua Fund Management Co., Ltd.
7,810,800
0.18%
-1,393,234
0.25%
12/31/2017
China Southern Asset Management Co., Ltd.
7,299,470
0.17%
-9,662,731
0.2%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
6,049,616
0.14%
-1,234,270
0.39%
12/31/2017
E Fund Management Co., Ltd.
5,918,539
0.13%
-2,907,387
0.12%
06/29/2018
Harvest Fund Management Co., Ltd.
4,870,811
0.11%
-15,850,385
0.1%
08/03/2018
The Vanguard Group, Inc.
3,720,418
0.08%
60,400
0%
07/31/2018
| Address |
Xiameilin Taike Road
Shenzhen Guangdong 518000
China
|
|
Employees
|
- |
| Website |
http://www.kangmei.com.cn |
| Updated |
07/08/2019 |
| Kangmei Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical, health care and health food products. It offers Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others, as well as chemical drugs, including Clarithromycin Dispersible Tablets, Doxazosin Mesylate Tablets, Propiverine Hydrochloride Tablets and paracetamol and pseudoephedrine hydrochloride tablets, among others. The company also provides property management services. |
